PLVAP-targeted ferritin nanocarriers and lysozyme-dextran nanogel nanocarriers have been demonstrated to provide effective and precise targeting [16, 28], as ferritin nanocarriers can easily pass through the BBB while loading glioma-targeted drugs [63, 64]. This evidence concerns the gene LYZ and central nervous system cancer.